Autopsy report · NCT02080195

Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

“Study was unable to accrue subjects”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 7 months before it started.
• Ran for about 7 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 1 year 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sponsor type

University, hospital or other

Conditions

Lupus Erythematosus; Graft-versus-host Disease

Interventions

Cyclophosphamide; Fludarabine; Tacrolimus; Mycophenolate Mofetil; Rabbit antithymocyte globulin; Total body irradiation

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Augmented Reality Heads-up Display to Improve Ultrasound Guided IV Access
  “Unable to enroll subjects.” (79% match in meaning)
• Sorafenib-induced Hand- Foot Skin Reaction Treatment
  “Study was halted due to poor subject accrual.” (79% match in meaning)
• Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
  “Study never accrued sufficient subjects” (79% match in meaning)
• Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis
  “unable to enroll any subjects” (78% match in meaning)
• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.